{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:04:31Z","timestamp":1794560671270,"version":"4.9.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T00:00:00Z","timestamp":1678147200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009438","name":"National Center of Neurology and Psychiatry","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014807","name":"Nagoya University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.eclinm.2023.101920","type":"journal-article","created":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T05:43:16Z","timestamp":1681450996000},"page":"101920","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["High-dose ubiquinol supplementation in multiple-system atrophy: a multicentre, randomised, double-blinded, placebo-controlled phase 2 trial"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7425-4765","authenticated-orcid":false,"given":"Jun","family":"Mitsui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Matsukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukari","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Kawahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayaka","family":"Chikada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine Joyce L.","family":"Porto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroya","family":"Naruse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Ishiura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsushi","family":"Toda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruko","family":"Kuzuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikue","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Ga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Moritoyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidehiro","family":"Mizusawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinya","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kuwabara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobukatsu","family":"Sawamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Onodera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Matsuse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Ichi","family":"Kira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9453-9311","authenticated-orcid":false,"given":"Masahisa","family":"Katsuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritsuko","family":"Hanajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhisa","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Takashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6585-3686","authenticated-orcid":false,"given":"Masaaki","family":"Matsushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Yabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenao","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoji","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2023.101920_bib1","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second consensus statement on the diagnosis of multiple system atrophy","volume":"71","author":"Gilman","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.eclinm.2023.101920_bib2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1056\/NEJMra1311488","article-title":"Multiple-system atrophy","volume":"372","author":"Fanciulli","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.eclinm.2023.101920_bib3","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/brain\/awf117","article-title":"Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients","volume":"125","author":"Watanabe","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.eclinm.2023.101920_bib4","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0304-3940(98)00407-8","article-title":"Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy","volume":"249","author":"Wakabayashi","year":"1998","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.eclinm.2023.101920_bib5","doi-asserted-by":"crossref","first-page":"a024588","DOI":"10.1101\/cshperspect.a024588","article-title":"\u03b1-Synuclein: multiple system atrophy prions","volume":"8","author":"Woerman","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.eclinm.2023.101920_bib6","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0140-6736(93)91789-O","article-title":"Multiple system atrophy: sporadic or familial?","volume":"342","author":"Wenning","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2023.101920_bib7","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archneur.64.4.545","article-title":"Multiplex families with multiple system atrophy","volume":"64","author":"Hara","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1016\/j.eclinm.2023.101920_bib8","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1212115","article-title":"Mutations in COQ2 in familial and sporadic multiple-system atrophy","volume":"369","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.eclinm.2023.101920_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.117623","article-title":"COQ2 V393A confers high risk susceptibility for multiple system atrophy in East Asian population","volume":"429","author":"Porto","year":"2021","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.eclinm.2023.101920_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147574","article-title":"Serum levels of coenzyme Q10 in patients with multiple system atrophy","volume":"11","author":"Kasai","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.eclinm.2023.101920_bib11","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1001\/jamaneurol.2016.1325","article-title":"Plasma coenzyme Q10 levels in patients with multiple system atrophy","volume":"73","author":"Mitsui","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.eclinm.2023.101920_bib12","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.parkreldis.2018.07.017","article-title":"Clinical correlates of decreased plasma coenzyme Q10 levels in patients with multiple system atrophy","volume":"57","author":"Du","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.eclinm.2023.101920_bib13","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.parkreldis.2017.10.010","article-title":"Cerebrospinal fluid levels of coenzyme Q10 are reduced in multiple system atrophy","volume":"46","author":"Compta","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.eclinm.2023.101920_bib14","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1016\/j.bbadis.2018.09.018","article-title":"Mitochondrial dysfunction in fibroblasts of multiple system atrophy","volume":"1864","author":"Monzio Compagnoni","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.eclinm.2023.101920_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149557","article-title":"Coenzyme Q10 levels are decreased in the cerebellum of multiple-system atrophy patients","volume":"11","author":"Schottlaender","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.eclinm.2023.101920_bib16","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/jnen\/nlw037","article-title":"Decreased coenzyme Q10 levels in multiple system atrophy cerebellum","volume":"75","author":"Barca","year":"2016","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"key":"10.1016\/j.eclinm.2023.101920_bib17","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.3389\/fnins.2019.01187","article-title":"Reductions in COQ2 expression relate to reduced ATP levels in multiple system atrophy brain","volume":"13","author":"Hsiao","year":"2019","journal-title":"Front Neurosci"},{"key":"10.1016\/j.eclinm.2023.101920_bib18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10048-018-0563-7","article-title":"Oxygen consumption rate for evaluation of COQ2 variants associated with multiple system atrophy","volume":"20","author":"Yasuda","year":"2019","journal-title":"Neurogenetics"},{"key":"10.1016\/j.eclinm.2023.101920_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-32573-1","article-title":"The pathogenesis linked to coenzyme Q10 insufficiency in iPSC-derived neurons from patients with multiple-system atrophy","volume":"8","author":"Nakamoto","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.eclinm.2023.101920_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-42902-7","article-title":"Cerebral mitochondrial electron transport chain dysfunction in multiple system atrophy and Parkinson's disease","volume":"9","author":"Foti","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.eclinm.2023.101920_bib21","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1007\/s12311-017-0846-9","article-title":"Three-year follow-up of high-dose ubiquinol supplementation in a case of familial multiple system atrophy with compound heterozygous COQ2 mutations","volume":"16","author":"Mitsui","year":"2017","journal-title":"Cerebellum"},{"key":"10.1016\/j.eclinm.2023.101920_bib22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.yrtph.2006.07.001","article-title":"Study on safety and bioavailability of ubiquinol (Kaneka QH) after single and 4-week multiple oral administration to healthy volunteers","volume":"47","author":"Hosoe","year":"2007","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.eclinm.2023.101920_bib23","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/ncn3.12566","article-title":"Randomized, double-blind, placebo-controlled phase 1 study to evaluate the safety and pharmacokinetics of high doses of ubiquinol in healthy adults","volume":"10","author":"Mitsui","year":"2022","journal-title":"Neurol Clin Neurosci"},{"key":"10.1016\/j.eclinm.2023.101920_bib24","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/mds.20255","article-title":"Development and validation of the unified multiple system atrophy rating scale (UMSARS)","volume":"19","author":"Wenning","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.eclinm.2023.101920_bib25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/ncn3.12477","article-title":"Reliability and validity of Japanese version of unified multiple system atrophy rating scale","volume":"9","author":"Chikada","year":"2021","journal-title":"Neurol Clin Neurosci"},{"key":"10.1016\/j.eclinm.2023.101920_bib26","first-page":"61","article-title":"Functional evaluation: the Barthel index","volume":"14","author":"Mahoney","year":"1965","journal-title":"Md State Med J"},{"key":"10.1016\/j.eclinm.2023.101920_bib27","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1212\/01.wnl.0000219042.60538.92","article-title":"Scale for the assessment and rating of ataxia: development of a new clinical scale","volume":"66","author":"Schmitz-H\u00fcbsch","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.eclinm.2023.101920_bib28","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/mds.22732","article-title":"Minocycline 1-year therapy in multiple-system-atrophy: effect on clinical symptoms and [(11)C] (R)-PK11195 PET (MEMSA-trial)","volume":"25","author":"Dodel","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.eclinm.2023.101920_bib29","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(13)70301-6","article-title":"Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trial","volume":"13","author":"Low","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.eclinm.2023.101920_bib30","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1474-4422(14)70288-1","article-title":"Efficacy of rasagiline in patients with the parkinsonian variant of multiple system atrophy: a randomised, placebo-controlled trial","volume":"14","author":"Poewe","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.eclinm.2023.101920_bib31","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/mds.23429","article-title":"Systematic review of levodopa dose equivalency reporting in Parkinson's disease","volume":"25","author":"Tomlinson","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.eclinm.2023.101920_bib32","first-page":"536","article-title":"Pharmacokinetic study of deuterium-labelled coenzyme Q10 in man","volume":"24","author":"Tomono","year":"1986","journal-title":"Int J Clin Pharmacol"},{"key":"10.1016\/j.eclinm.2023.101920_bib33","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/mds.26743","article-title":"Minimally clinically important decline in the parkinsonian variant of multiple system atrophy","volume":"31","author":"Krismer","year":"2016","journal-title":"Mov Disord"},{"key":"10.1016\/j.eclinm.2023.101920_bib34","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/1545968306294729","article-title":"Establishing the minimal clinically important difference of the Barthel Index in stroke patients","volume":"21","author":"Hsieh","year":"2007","journal-title":"Neurorehabil Neural Repair"},{"key":"10.1016\/j.eclinm.2023.101920_bib35","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1002\/mds.21734","article-title":"Potential outcome measures and trial design issues for multiple system atrophy","volume":"22","author":"May","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.eclinm.2023.101920_bib36","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s12311-015-0686-4","article-title":"Comparison of different symptom assessment scales for multiple system atrophy","volume":"15","author":"Matsushima","year":"2016","journal-title":"Cerebellum"},{"key":"10.1016\/j.eclinm.2023.101920_bib37","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1002\/mds.22408","article-title":"Safety and tolerability of high-dosage coenzyme Q10 in Huntington's disease and healthy subjects","volume":"25","author":"Hyson","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.eclinm.2023.101920_bib38","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S1474-4422(19)30141-3","article-title":"Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial","volume":"18","author":"Levin","year":"2019","journal-title":"Lancet Neurol"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537023000974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537023000974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:19:35Z","timestamp":1762899575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537023000974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":38,"alternative-id":["S2589537023000974"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2023.101920","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-dose ubiquinol supplementation in multiple-system atrophy: a multicentre, randomised, double-blinded, placebo-controlled phase 2 trial","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2023.101920","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101920"}}